1. Home
  2. GVH vs SCNI Comparison

GVH vs SCNI Comparison

Compare GVH & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globavend Holdings Limited

GVH

Globavend Holdings Limited

HOLD

Current Price

$1.23

Market Cap

2.7M

Sector

N/A

ML Signal

HOLD

SCNI

Scinai Immunotherapeutics Ltd.

HOLD

Current Price

$1.00

Market Cap

2.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GVH
SCNI
Founded
2016
2003
Country
Australia
Israel
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7M
2.6M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
GVH
SCNI
Price
$1.23
$1.00
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$80.00
N/A
AVG Volume (30 Days)
177.6K
53.8K
Earning Date
01-30-2026
03-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
11.95
0.26
Revenue
$21,878,867.00
$1,147,000.00
Revenue This Year
$141,706.20
N/A
Revenue Next Year
$3.35
N/A
P/E Ratio
$0.10
$3.72
Revenue Growth
24.52
303.87
52 Week Low
$1.09
$0.61
52 Week High
$364.00
$6.18

Technical Indicators

Market Signals
Indicator
GVH
SCNI
Relative Strength Index (RSI) 33.08 54.77
Support Level $1.17 $0.93
Resistance Level $1.29 $1.12
Average True Range (ATR) 0.11 0.09
MACD 0.08 0.02
Stochastic Oscillator 34.21 60.84

Price Performance

Historical Comparison
GVH
SCNI

About GVH Globavend Holdings Limited

Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

Share on Social Networks: